California Institute of Technology

California Institute of Technology

California Institute of Technology

Overview
Date Founded

1891

Headquarters

1200 CALIFORNIA BLVD MC 169-84 PASADENA CA 91125-0001

Charitable Causes

Higher Education & Universities
Education Research & Support

Employees (Worldwide)

11.8K

Industries

Social Interest
Investment Services & Portfolio Management
Schools & Student Services
Computer Software

Company Description

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Contact Data
Trying to get in touch with decision makers at California Institute of Technology? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Executive Assistant to President/Assistant Secretary

Executive Director of Office of Technology Transfer

Vice President of Administration & Chief Financial Officer

Chief Investment Officer

General Counsel

Provost

David Morrisroe Professor of Physics, Vice Provost for Special Projects

Controller

Harold Brown Professor of Physics, Emeritus, Director, Spitzer Science Center

Distinguished Alumni
George M. Whitesides is now Co-Founder at Innoviva, Inc.
Pedro J. Pizarro is now President, Chief Executive Officer & Director at Edison International
Paths to California Institute of Technology
Potential Connections via
Relationship Science
You
California Institute of Technology
Advisors & Consultants
Legal Advisor

Partner at Sidley Austin LLP

Consultant

Partner at ZGF Architects LLP

Legal Advisor
Clients

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Sangamo is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs. We are worldwide leaders in the development of a proprietary technology platform that enables specific regulation of gene expression and gene modification. The basis of this platform is a naturally occurring class of transcription factors, zinc finger DNA-binding proteins (ZFPs) which we can engineer to drive desired therapeutic outcomes. Engineered ZFPs can be linked to functional domains that normally activate or repress gene expression to create ZFP transcription factors (ZFP TFs) capable of turning genes on or off. We can also link ZFPs to nuclease domains to create zinc finger nucleases (ZFNs) which enable precise gene-editing in cells. Engineered ZFNs can modify a cell's DNA at a precise location, thereby facilitating correction or disruption of a specific gene or the targeted addition of a new DNA sequence. Sangamo was founded in 1995, went public in 2000, and trades on the Nasdaq Global Market (SGMO). We are located in Richmond, California, in the Bay Area, the birthplace of biotechnology. We are intimately involved in our community through partnerships with academic institutions, relationships with non-profit organizations and ties to advocacy organizations aligned with improving the quality of life for patients with unmet medical needs within our strategic vision.

Fluidigm Corp. is engaged in the development, manufacture and marketing of biotechnology tools fro life sciences research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics; and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen R. Quake and Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$3.69B
Non-Profit Donations & Grants Received
$25K
12/31/2019
$2,000
12/31/2019
$25K
06/30/2019
Investments
Details Hidden

Foldax, Inc. develops synthetic heart valves for delivering non-thrombogenic aortic and mitral valves. The company is headquartered in Salt Lake City, UT.

Details Hidden

ChromaCode, Inc. develops software and manufactures laboratory instruments. It uses digital signal processing to improve clinical molecular analysis. The company was founded by Aditya Rajagopal, Alexander G. Dickinson, Axel Scherer, and Gregory J. Gosch in 2012 and is headquartered in Carlsbad, CA.

Details Hidden

Coursera, Inc. is an online learning platform that offers anyone, anywhere access to online courses and degrees from universities and companies. Its courses include arts, chemistry, engineering, food and nutrition, health, humanities, law, medicine, and music. The company was founded by Daphne Koller and Andrew Y. Ng and is headquartered in Mountain View, CA.

Investors
Details Hidden

Co-Founder at The Wonderful Co. LLC

Details Hidden

Chief Executive Officer at Teleflora LLC

Suppliers
Jaggaer LLC Pension Funds & Sovereign Wealth | Morrisville, NC

Jaggaer LLC provides cloud-based business automation solutions for spend management. It offers spend analysis, savings management, sourcing, supplier management, accounts payable, contract lifecycle management, and inventory management solutions. The company was founded in 1995 and is headquartered in Morrisville, NC.

Targacept, Inc. Pharmaceuticals | Winston-salem, NC

Targacept, Inc. is a biopharmaceutical company developing a diverse pipeline of NNR TherapeuticsTM. NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity. We have a clinical-stage product pipeline that includes multiple Phase 2 product candidates with distinct NNR pharmacologies. Our most advanced product candidates are being developed for negative symptoms and cognitive dysfunction in schizophrenia, overactive bladder and Alzheimer’s disease

Lockheed Martin Corporation Aerospace & Defense | Bethesda, MD

Lockheed Martin Corp. operates as a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS) and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment provides air and missile defence systems; tactical missiles and air-to-ground precision strike weapon systems; logistics; fire control systems; mission operations support, readiness, engineering support and integration services; manned and unmanned ground vehicles; and energy management solutions. The RMS segment offers design, manufacture, service, and support for a variety of military and commercial helicopters; ship and submarine mission and combat systems; mission systems and sensors for rotary and fixed-wing aircraft; sea and land-based missile defence systems; radar systems; the Littoral Combat Ship; simulation and training services; and unmanned systems and technologies. The Space segment comprises of the research and development, design, engineering and production of satellites, strategic, and defensive missile systems and space transportation systems. The company was founded in 1961 and is headquartered in Bethesda, MD.

Awards & Honors
Rank #167
2010
The Chronicle of Philanthropy - Philanthropy 400
Rank #206
2009
The Chronicle of Philanthropy - Philanthropy 400
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by California Institute of Technology. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of California Institute of Technology's profile does not indicate a business or promotional relationship of any kind between RelSci and California Institute of Technology.